SM

Sai Mohana Krishna Kodipilla

Active Director Director DIN 11226358
DIN 11226358 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sai Mohana Krishna Kodipilla

Data last updated:

Sai Mohana Krishna Kodipilla is a Director at Belsohn Scientia Private Limited (since 2025). The company operates in Pharma.

DIN 11226358
Primary Designation Director
Industry Pharma
First Appointment 03 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Belsohn Scientia Private Limited U47721AP2025PTC120570
Director03 Aug 20252025Active

Board colleagues of Sai Mohana Krishna Kodipilla

NameDINCompanyDesignation
Rajasekhar Jonnalagadda11226359Belsohn Scientia Private LimitedDirector

Directorship timeline

Open interactive timeline →
Belsohn Scientia Private Limited
Premium access

Shareholding and investment profile for Sai Mohana Krishna Kodipilla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Mohana Krishna Kodipilla

Sai Mohana Krishna Kodipilla currently holds 1 directorship: Belsohn Scientia Private Limited (Director, since 03 Aug 2025).

Sai Mohana Krishna Kodipilla was first appointed on 03 Aug 2025 as Director at Belsohn Scientia Private Limited.

The current boards of Sai Mohana Krishna Kodipilla's companies include Rajasekhar Jonnalagadda (Belsohn Scientia Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available